<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmacology / Pharmacy / Tort law / FDA Preemption / Wyeth v. Levine / Pharmaceutical industry / Riegel v. Medtronic /  Inc. / Medical device / Pharmaceutical sciences / Medicine / Law
Date: 2009-03-09 09:39:48
Food and Drug Administration
Pharmacology
Pharmacy
Tort law
FDA Preemption
Wyeth v. Levine
Pharmaceutical industry
Riegel v. Medtronic
Inc.
Medical device
Pharmaceutical sciences
Medicine
Law

Project FDA Report James R. Copland Director, Center for Legal Policy Manhattan Institute for Policy Research Paul Howard

Add to Reading List

Source URL: www.manhattan-institute.org

Download Document from Source Website

File Size: 1,93 MB

Share Document on Facebook

Similar Documents

Microsoft Word - DDB-March-06.doc

Microsoft Word - DDB-March-06.doc

DocID: 1pk5y - View Document

IN THE SUPREME COURT OF FLORIDA CASE NO.: SC10-557 LT NO.: 3D08-1563 McNEIL – P.P.C., INC., Petitioner, v.

IN THE SUPREME COURT OF FLORIDA CASE NO.: SC10-557 LT NO.: 3D08-1563 McNEIL – P.P.C., INC., Petitioner, v.

DocID: RkiN - View Document

Project FDA Report  James R. Copland Director, Center for Legal Policy Manhattan Institute for Policy Research Paul Howard

Project FDA Report James R. Copland Director, Center for Legal Policy Manhattan Institute for Policy Research Paul Howard

DocID: QNSI - View Document

Case: [removed]Document: [removed]Page: 1

Case: [removed]Document: [removed]Page: 1

DocID: FGhz - View Document

BOYD[removed]Do Not Delete[removed]:19 PM UNEQUAL PROTECTION UNDER THE LAW: WHY FDA SHOULD USE NEGOTIATED RULEMAKING TO REFORM

BOYD[removed]Do Not Delete[removed]:19 PM UNEQUAL PROTECTION UNDER THE LAW: WHY FDA SHOULD USE NEGOTIATED RULEMAKING TO REFORM

DocID: ASvX - View Document